CommentarySGLT2 inhibition during the COVID-19 epidemic: Friend or foe?
Keywords
Adipose tissue
COVID-19
Inflammation
Ketoacidosis
SGLT2 inhibitor
Cited by (0)
© 2020 Elsevier Masson SAS. All rights reserved.